Aveanna Healthcare (NASDAQ:AVAH) Upgraded at Raymond James Financial

Key Points

• Aveanna Healthcare's stock has been upgraded by Raymond James Financial from a "market perform" rating to an "outperform" rating, with a price target of $9.00, indicating a potential upside of 46.58% from its previous close.
• The stock has a current market capitalization of $1.20 billion and has seen a fifty-two week price range between $3.67 and $6.46.
• Insider selling has occurred, with notable transactions by CAO Deborah Stewart and major shareholder J.H. Whitney Equity Partners, who sold shares valued at around $4 million combined.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) was upgraded by analysts at Raymond James Financial from a "market perform" rating to an "outperform" rating in a note issued to investors on Monday, August 11th, MarketBeat.com reports. The brokerage presently has a $9.00 price target on the stock. Raymond James Financial's target price would suggest a potential upside of 26.51% from the stock's current price.

A number of other brokerages have also commented on AVAH. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Jefferies Financial Group upgraded shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and decreased their price target for the company from $6.25 to $6.00 in a research note on Monday, July 21st. Wall Street Zen upgraded shares of Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Barclays started coverage on shares of Aveanna Healthcare in a research note on Wednesday, July 2nd. They issued an "equal weight" rating and a $5.50 price target on the stock. Finally, UBS Group upped their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research note on Friday, May 9th. One research analyst has rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Aveanna Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $6.45.

Aveanna Healthcare Stock Performance

AVAH traded up $0.03 on Monday, reaching $7.11. The company had a trading volume of 420,893 shares, compared to its average volume of 522,530. Aveanna Healthcare has a fifty-two week low of $3.67 and a fifty-two week high of $7.61. The stock has a market cap of $1.49 billion, a P/E ratio of 89.06 and a beta of 1.95. The company's fifty day moving average is $4.77 and its 200 day moving average is $4.87.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the sale, the insider owned 28,890,756 shares of the company's stock, valued at approximately $150,231,931.20. The trade was a 2.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the sale, the insider directly owned 28,890,756 shares in the company, valued at approximately $150,231,931.20. The trade was a 2.53% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,295,145 shares of company stock worth $11,941,141 in the last three months. Company insiders own 7.00% of the company's stock.

Institutional Trading of Aveanna Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. Millennium Management LLC grew its stake in shares of Aveanna Healthcare by 105.0% during the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after buying an additional 205,023 shares during the last quarter. Legal & General Group Plc lifted its holdings in shares of Aveanna Healthcare by 577.0% during the fourth quarter. Legal & General Group Plc now owns 36,409 shares of the company's stock worth $166,000 after purchasing an additional 31,031 shares during the period. Deutsche Bank AG lifted its holdings in shares of Aveanna Healthcare by 32.1% during the fourth quarter. Deutsche Bank AG now owns 34,564 shares of the company's stock worth $158,000 after purchasing an additional 8,396 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth $223,000. Finally, Teacher Retirement System of Texas lifted its holdings in shares of Aveanna Healthcare by 50.9% during the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company's stock worth $270,000 after purchasing an additional 16,835 shares during the period. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.